drugset / Trial / NCT02183220

Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache

NCT02183220

Phase 3 Completed 417 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the study was to evaluate the efficacy, safety and tolerability of a single peroral dose of 0.5 g and 1.0 g metamizol relative to placebo and 1.0 g acetylsalicylic acid in 2 episodes of moderate tension headache.

Timeline

Start
1998-10
Primary completion
1999-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 1 g
Subject dipyrone Unknown 0.5 g Oral
Subject dipyrone Unknown 1 g Oral

Indications